A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

Akira IizukaChizu NonomuraTadashi AshizawaRyota KondouKeiichi OhshimaTakashi SuginoKoichi MitsuyaNakamasa HayashiYoko NakasuKouji MaruyamaKen YamaguchiYasuto Akiyama

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

An anti-B7-H4/CD3 BsAb may be a good therapeutic tool for patients with B7-H4+ breast cancers.

Keyphrases

endothelial cells
nk cells
pluripotent stem cells
young adults
childhood cancer